Literature DB >> 19442740

Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells.

Yonghong Zhao1, Lester Gutshall, Haiyan Jiang, Audrey Baker, Eric Beil, Galina Obmolova, Jill Carton, Susann Taudte, Bernard Amegadzie.   

Abstract

Fab (fragment that having the antigen binding site) of a monoclonal antibody (mAb) is widely required in biopharmaceutical research and development. At Centocor, two routes of Fab production and purification were used to enable a variety of research and development efforts, particularly, crystallographic studies of antibody-antigen interactions. One route utilizes papain digestion of an intact monoclonal antibody for Fab fragment production. After digestion, separation of the Fab fragment from the Fc (fragment that crystallizes) and residual intact antibody was achieved using protein A affinity chromatography. In another route, His-tagged Fab fragments were obtained by transient expression of an appropriate construct in mammalian cells, and typical yields are 1-20mg of Fab fragment per liter of cell culture. The His-tagged Fab fragments were first captured using immobilized metal affinity chromatography (IMAC). To provide high quality protein sample for crystallization, Fabs from either proteolytic digestion or from direct expression were further purified using size-exclusion chromatography (SEC) and/or ion-exchange chromatography (IEC). The purified Fab fragments were characterized by mass spectrometry, SDS-PAGE, dynamic light scattering, and circular dichroism. Crystallization experiments demonstrated that the Fab fragments are of high quality to produce diffraction quality crystals suitable for X-ray crystallographic analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442740     DOI: 10.1016/j.pep.2009.04.012

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  22 in total

1.  Crystallization of a challenging antigen-antibody complex: TLR3 ECD with three noncompeting Fabs.

Authors:  Thomas J Malia; Galina Obmolova; Jinquan Luo; Alexey Teplyakov; Raymond Sweet; Gary L Gilliland
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-30

2.  Improved Protein-A separation of V(H)3 Fab from Fc after papain digestion of antibodies.

Authors:  Therese A Seldon; Karen E Hughes; David J Munster; David Y Chin; Martina L Jones
Journal:  J Biomol Tech       Date:  2011-07

3.  Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.

Authors:  Hao Hong; Yin Zhang; Hakan Orbay; Hector F Valdovinos; Tapas R Nayak; Jero Bean; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Mol Pharm       Date:  2013-01-14       Impact factor: 4.939

4.  Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure.

Authors:  Jinquan Luo; Galina Obmolova; Thomas J Malia; Sheng-Jiun Wu; Karen E Duffy; James D Marion; Jessica K Bell; Peng Ge; Z Hong Zhou; Alexey Teplyakov; Yonghong Zhao; Roberta J Lamb; Jarrat L Jordan; Lani R San Mateo; Raymond W Sweet; Gary L Gilliland
Journal:  J Mol Biol       Date:  2012-05-09       Impact factor: 5.469

5.  An immunosensor based on antibody binding fragments attached to gold nanoparticles for the detection of peptides derived from avian influenza hemagglutinin H5.

Authors:  Urszula Jarocka; Róża Sawicka; Anna Góra-Sochacka; Agnieszka Sirko; Włodzimierz Zagórski-Ostoja; Jerzy Radecki; Hanna Radecka
Journal:  Sensors (Basel)       Date:  2014-08-25       Impact factor: 3.576

6.  A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.

Authors:  Guipeng Ding; Ximin Chen; Jin Zhu; Nicholas S Duesbery; Xunjia Cheng; Brian Cao
Journal:  Clin Dev Immunol       Date:  2013-06-05

7.  Research applications of proteolytic enzymes in molecular biology.

Authors:  János András Mótyán; Ferenc Tóth; József Tőzsér
Journal:  Biomolecules       Date:  2013-11-08

8.  Protein crystallization with microseed matrix screening: application to human germline antibody Fabs.

Authors:  Galina Obmolova; Thomas J Malia; Alexey Teplyakov; Raymond W Sweet; Gary L Gilliland
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-07-23       Impact factor: 1.056

9.  Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.

Authors:  Anna Gaciarz; Johanna Veijola; Yuko Uchida; Mirva J Saaranen; Chunguang Wang; Sohvi Hörkkö; Lloyd W Ruddock
Journal:  Microb Cell Fact       Date:  2016-01-25       Impact factor: 5.328

Review 10.  Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens.

Authors:  Lassi Liljeroos; Enrico Malito; Ilaria Ferlenghi; Matthew James Bottomley
Journal:  J Immunol Res       Date:  2015-10-07       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.